DocGo Inc.
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $322.2M | $616.6M | $624.3M | $440.5M | $318.7M |
| Operating income | -$178.0M | $28.7M | $15.1M | $21.8M | $15.4M |
| Operating expenses | $500.2M | $587.9M | $609.2M | $418.7M | $303.4M |
| Cost of revenue | — | — | — | $523.9M | $451.7M |
| Cash from operations | $34.5M | $70.1M | -$64.5M | $28.9M | -$1.9M |
| Capital expenditure | $4.5M | $3.6M | $7.3M | $3.2M | $4.8M |
| Free cash flow | $29.9M | $66.5M | -$71.8M | $25.7M | -$6.8M |
| Share repurchases | $10.8M | $13.8M | $0 | $3.7M | $0 |
| Impairments | $58.2M | $0 | $0 | $2.9M | $0 |
| Total assets | $217.1M | $455.6M | $490.5M | $393.3M | $309.6M |
| Total liabilities | $91.2M | $140.4M | $185.3M | $114.4M | $82.5M |
Shares outstanding 98.8M · Free float 91.9%
Annual filing data through FY ended December 31, 2025; float as of June 27, 2026.